The Current Ratio as of September 2024 (TTM) for Alterity Therapeutics Limited (ATHE) is 6.17

According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 6.17. This represents a change of Infinity% compared to the average of 0 of the last 4 quarters.

Alterity Therapeutics Limited (ATHE) Historical Current Ratio (quarterly & annually)

How has ATHE Current Ratio performed in the past?

The mean historical Current Ratio of Alterity Therapeutics Limited over the last ten years is 9.81. The current 6.17 Current Ratio has changed 6.19% with respect to the historical average. Over the past ten years (40 quarters), ATHE's Current Ratio was at its highest in in the September 2015 quarter at 16.39. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Alterity Therapeutics Limited (ATHE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alterity Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alterity Therapeutics Limited (ATHE) Average Current Ratio

How has ATHE Current Ratio performed in the past?

The current Current Ratio of Alterity Therapeutics Limited (ATHE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alterity Therapeutics Limited (ATHE) Current Ratio vs. Peers

How is ATHE’s Current Ratio compared to its peers?

Alterity Therapeutics Limited’s Current Ratio is greater than Anebulo Pharmaceuticals, Inc. (5.32), less than PMV Pharmaceuticals, Inc. (19.22), less than AN2 Therapeutics, Inc. (10.61), less than Eliem Therapeutics, Inc. (60.41), greater than HCW Biologics Inc. (0.10), less than Protara Therapeutics, Inc. (16.33), greater than Vaccinex, Inc. (0.42), less than Monopar Therapeutics Inc. (6.59), greater than Miromatrix Medical Inc. (3.46), less than Surrozen, Inc. (6.96), greater than NovaBay Pharmaceuticals, Inc. (0.62), less than ARCA biopharma, Inc. (26.61), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than Artelo Biosciences, Inc. (14.58), greater than Adial Pharmaceuticals, Inc. (5.69), greater than TransCode Therapeutics, Inc. (1.25), greater than Aditxt, Inc. (0.07), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Avenue Therapeutics, Inc. (4.30),

Build a custom stock screener for Alterity Therapeutics Limited (ATHE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alterity Therapeutics Limited (ATHE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.